1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
61ECD49B872C2CC7700258C4A0021EBCB
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-medical-affairs-cns-patient-engagement-amplifying-patient-voice-support-strategies?opendocument
18
19opendocument
2018.97.9.171
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Patient Advocacy

Medical Affairs and CNS Patient Engagement: Amplifying the Patient Voice and Patient Support Strategies

ID: 5859


Features:

13 Info Graphics

15 Data Graphics

230+ Metrics

10 Narratives


Pages/Slides: 36


Published: 2025


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Medical Affairs and CNS Patient Engagement: Amplifying the Patient Voice and Patient Support Strategies”


STUDY OVERVIEW

With CNS patients’ experiences often shaped by both chronic and acute phases of their conditions, engaging them through the right support strategies is essential. Medical Affairs groups play a critical role in ensuring the patient voice is not only heard but actively integrated into every stage of development.

Best Practices, LLC conducted this study to explore how Medical Affairs can integrate patient support strategies at both early and late stages of development in the CNS space. This research covers strategies to ensure the patient voice is represented and highlights key opportunities for collaboration with patient advocacy groups.

Data in this study are segmented by respondents’ description of their medical team’s effectiveness with patient engagement – highly effective vs. less effective.

KEY TOPICS

  • CNS Patient Engagement Overview
  • Strategies to Reflect the Central Nervous System Patient Voice
  • Early and Late-Stage CNS Patient Support
  • Working with CNS Patient Advocacy Groups

KEY METRICS

  • Effectiveness of Medical Affairs groups in representing the CNS patient voice
  • Effectiveness of tools and strategies used by Medical Affairs to collect the CNS patient voice during the pre-launch and launch phases
  • Impact of various approaches in supporting CNS patients at early and late stages of their condition
  • Medical Affairs groups' working relationships with CNS patient advocacy organizations

SAMPLE KEY FINDINGS

  • Early-Stage CNS Patient Support: Partnering with advocacy groups and disease awareness education are the most effective early-stage support strategies.

METHODOLOGY

Best Practices, LLC engaged 12 Medical leaders from 12 CNS-focused pharma companies through a benchmarking survey, supplementing findings with in-depth interviews for deeper insights. The study segments data based on Medical teams' self-assessed effectiveness in CNS patient engagement—highly effective vs. less effective.

Industries Profiled:
Pharmaceutical; Service; Consulting; Health Care; Biotech; Biopharmaceutical; Clinical Research; Laboratories; Communications


Companies Profiled:
AbbVie; Boehringer Ingelheim; EVERSANA; Kyowa Kirin; MEDiSTRAVA; Merck; NextGen Healthcare; Sanofi; Sunovion; Supernus; Takeda Pharmaceuticals; The Medicine Group

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.